---
title: "AZENCO2 LIMITED — Ownership Dossier"
canonical: https://whiteintel.dev/entity/10676c92-cbd8-50d2-91dd-3f95b181b950
json: https://whiteintel.dev/api/public/dossier/10676c92-cbd8-50d2-91dd-3f95b181b950
identifier: oo:GB-COH-09406851
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# AZENCO2 LIMITED

**Type:** Company  
**Jurisdiction:** [GB](https://whiteintel.dev/jurisdictions/gb)  
**Identifier:** `oo:GB-COH-09406851`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/10676c92-cbd8-50d2-91dd-3f95b181b950  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/10676c92-cbd8-50d2-91dd-3f95b181b950  

## Ownership & control

### Owners / controllers

- **ASTRAZENECA TREASURY LIMITED** (beneficial owner) — 100% — https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff
- **ASTRAZENECA TREASURY LIMITED** (beneficial owner) — 87.5% — https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff

### UBO chain (walk to the ultimate owner)

A **10-step** ownership/control chain to the ultimate beneficial owner is resolved for this entity. The full cited chain unlocks with a paid API key or a one-off dossier — https://whiteintel.dev/pricing.

## Company profile (live · UK Companies House)

- **Company number:** `09406851`
- **Status:** dissolved
- **Type:** ltd
- **Incorporated:** 2015-01-26
- **Registered office:** 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, CB2 0AA, United Kingdom
- **SIC:** 82990

### Officers

- JOHNSTONE, Camilla Jane — secretary · appointed 2019-07-31
- BOWDEN, Matthew Shaun — director · British · appointed 2019-02-27
- COLLINS, Iain Alistair — director · British · appointed 2017-05-31
- TATTERSALL, Hannah Victoria — director · British · appointed 2025-05-01
- CONACHER, Matthew Ian — secretary · appointed 2017-03-16 · resigned 2019-07-31
- JACKSON-TURNER, Katie Louise — secretary · appointed 2015-07-15 · resigned 2017-03-16
- O'GRADY, Claire-Marie — secretary · appointed 2015-01-26 · resigned 2015-07-31
- BRIMICOMBE, Ian Martin David — director · British · appointed 2015-01-26 · resigned 2017-05-31
- JACKSON-TURNER, Katie Louise — director · British · appointed 2017-03-16 · resigned 2019-02-27
- KEMP, Adrian Charles Noel — director · British · appointed 2015-01-26 · resigned 2025-05-01

### Beneficial owners (Persons with Significant Control)

- [Astrazeneca Treasury Limited](https://whiteintel.dev/entity/2763a136-67ee-56fe-abd4-5d5b1cf5dbff) — 75–100% shares · corporate PSC · England — since 2016-04-06

## Provenance

- OpenOwnership — https://find-and-update.company-information.service.gov.uk/company/09406851

## Get the full, resolved dossier (agent-callable)

The above is the free teaser. The resolved **multi-hop UBO chain**, ownership **%**, full **financial history**, itemised **assets** and the hop-by-hop **exposure path** are the paid depth — callable as tools from your agent:

```bash
npx -y @whiteintel/mcp-server   # then: get_dossier · trace_ownership_path · check_offshore_exposure
```

Or unlock a one-off cited dossier for **AZENCO2 LIMITED** — https://whiteintel.dev/entity/10676c92-cbd8-50d2-91dd-3f95b181b950 · pricing https://whiteintel.dev/pricing.

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **AZENCO2 LIMITED**. Human view: https://whiteintel.dev/entity/10676c92-cbd8-50d2-91dd-3f95b181b950 · Structured JSON: https://whiteintel.dev/api/public/dossier/10676c92-cbd8-50d2-91dd-3f95b181b950._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._